Perspective Therapeutics (CATX) Other Non Operating Income (2010 - 2025)
Perspective Therapeutics (CATX) posted Other Non Operating Income of $1.4 million for Q1 2025, up 70100.0% sequentially from -$2000.0 in Q4 2023.
Perspective Therapeutics (CATX) Other Non Operating Income (2010 - 2025) Analysis & Trends
Perspective Therapeutics has reported Other Non Operating Income for 12 years, with the latest figure at $1.4 million in Q1 2025.
- Quarterly Other Non Operating Income changed N/A year-over-year to $1.4 million in Q1 2025, while the trailing twelve-month figure through Mar 2026 was $1.4 million (changed 0.14% YoY) and the FY2025 annual result came in at $1.4 million, changed N/A from the prior year.
- Other Non Operating Income advanced to $1.4 million in Q1 2025 per CATX's latest filing, from -$2000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.4 million in Q1 2025 and troughed at -$2000.0 in Q4 2023.
- A 3-year average of $365500.0 and a median of $32000.0 in 2022 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 103.23% in 2023, down 103.23% in 2023.
- Over 3 years, Other Non Operating Income stood at $62000.0 in 2022, then tumbled by 103.23% to -$2000.0 in 2023, then surged by 70100.0% to $1.4 million in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $1.4 million, -$2000.0, and $2000.0 for Q1 2025, Q4 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 387.89 Mn | 387.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2023 | -2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Dec 31, 2022 | 62,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Jun 30, 2017 | 7,000.00 |
| Sep 30, 2016 | 20,000.00 |
| Jun 30, 2016 | 18,000.00 |
| Mar 31, 2016 | 78,000.00 |
| Jun 30, 2015 | -605.00 |
| Mar 31, 2015 | 28,605.00 |
| Dec 31, 2014 | 41,000.00 |
| Sep 30, 2014 | 306,000.00 |
| Jun 30, 2014 | -368,134.00 |
| Mar 31, 2014 | -1.10 Mn |
| Dec 31, 2013 | 117,000.00 |
| Sep 30, 2013 | -36,000.00 |
| Jun 30, 2013 | 25,000.00 |
| Mar 31, 2013 | 109,000.00 |
| Dec 31, 2012 | -55,000.00 |